WeVote

Bill

Bill

SB 5019

Concerning prepacked medication distribution.

2025-2026 Regular Session Introduced by Jess Bateman and 8 co-sponsors

SB 5019 establishes safety standards and regulatory requirements for prepacked medication distribution in Washington healthcare settings to reduce errors and ensure proper oversight.

Senate Rules "X" file.
0
WeVote Research Nonpartisan
Bill Summary · SB 5019

Legislative bill overview

SB 5019 establishes regulations for the distribution of prepacked medications—pharmaceuticals that are pre-packaged by manufacturers or authorized third parties rather than individually dispensed by pharmacists. The bill creates standards for labeling, handling, storage, and oversight of these prepacked medications to ensure safety and traceability in healthcare settings.

Why is this important

Prepacked medication distribution has grown significantly in hospitals, clinics, and long-term care facilities as an efficiency measure, but it creates gaps in traditional pharmacist oversight and quality control. The bill addresses safety concerns around medication errors, contamination, and accountability by establishing uniform state standards that currently don't exist, potentially affecting medication safety for vulnerable populations in institutional care settings.

Potential points of contention

  • Pharmacist authority: Traditional pharmacy stakeholders may oppose reduced pharmacist involvement in medication preparation and oversight, viewing prepacked systems as encroaching on professional scope
  • Implementation costs: Healthcare facilities and manufacturers may face increased expenses from new labeling requirements, tracking systems, and compliance procedures
  • Definition and scope: Disagreement over which medications qualify for prepacking versus those requiring individual pharmacist dispensing, and whether exemptions should exist for certain facility types

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.